Nanobiotix (NBTX) Intangibles (2018 - 2025)
Nanobiotix's (NBTX) quarterly Intangibles came in at $11640.4 in Q4 2025, up 55.62% year-on-year from $7480.2 in Q4 2024, and down 20.9% quarter-over-quarter from $14715.5 in Q2 2025.
Nanobiotix (NBTX) Intangibles (2018 - 2025) Analysis & Trends
Nanobiotix's Intangibles history runs 8 years deep, the most recent figure standing at $11640.4 for Q4 2025.
- On a quarterly basis, Intangibles rose 55.62% year-over-year to $11640.4 in Q4 2025; TTM through Dec 2025 was $11640.4, a 55.62% increase from a year earlier, with the FY2025 full-year figure at $11298.1, up 51.04% from the prior year.
- Intangibles slipped to $11640.4 in Q4 2025 per NBTX's latest filing, from $14715.5 in the prior quarter.
- Across five years, Intangibles topped out at $14715.5 in Q2 2025 and bottomed at -$1088.9 in Q2 2023.
- The 5-year median for Intangibles is $8043.8 (2023), against an average of $7216.1.
- Across the five-year window, Intangibles tumbled 202.05% in 2023 and surged 990.05% in 2024, its largest moves.
- Year by year, Intangibles stood at $4575.9 in 2021, then sank by 77.7% to $1020.2 in 2022, then soared by 743.67% to $8607.5 in 2023, then slipped by 13.1% to $7480.2 in 2024, then surged by 55.62% to $11640.4 in 2025.
- Per Business Quant, the three latest NBTX Intangibles figures stand at $11640.4 (Q4 2025), $14715.5 (Q2 2025), and $7480.2 (Q4 2024).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11,640.44 |
| Jun 30, 2025 | 14,715.48 |
| Dec 31, 2024 | 7,480.17 |
| Jun 30, 2024 | 9,691.99 |
| Dec 31, 2023 | 8,607.52 |
| Jun 30, 2023 | -1,088.92 |
| Dec 31, 2022 | 1,020.25 |
| Jun 30, 2022 | 1,067.06 |
| Dec 31, 2021 | 4,575.88 |
| Jun 30, 2021 | 14,451.26 |
| Dec 31, 2020 | 25,038.09 |
| Dec 31, 2019 | 180,422.69 |
| Dec 31, 2018 | 116,422.44 |